Floatz logo

Panobinostat

Basal Cell Neoplasm

UNC Lineberger Comprehensive Cancer CenterSmall moleculePhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Basal Cell Neoplasm cohort.

Asset / SponsorPhaseRating
Eloxatin
UNC Lineberger Comprehensive Cancer Center
Phase 1/2CC
Irinotecan
UNC Lineberger Comprehensive Cancer Center
Phase 1/2CC
FLUOROURACILUM
UNC Lineberger Comprehensive Cancer Center
Phase 1/2CC
Calcium folinate pentahydrate
UNC Lineberger Comprehensive Cancer Center
Phase 1/2CC

Same molecule, other indications

Panobinostat is also rated in:

Hodgkins lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
Non-Small Cell Lung CancerDormant
BB
Indicative ·
66 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →